Multiple lineage-specific surface molecules have recently been defined on human T lymphocytes. Although some of these appear during late intrathymic ontogeny and are maintained on all peripheral T cells (T3), others (T4, TS) arise earlier in differentiation and are selectively expressed on functional subpopulations of human T lymphocytes (1-3). In the case of the 20,000-mol wt T3 surface molecule, both its appearance in intrathymic ontogeny at the time of acquisition of immunologic competence (1, 4) and its critical role in T lymphocyte function suggested that it was closely linked to a recognition receptor for antigen. Thus, antibodies directed against T3 were able to block both the induction and the effector phase of cell-mediated lympholysis, inhibit T lymphocyte proliferative responses to soluble antigen, and be mitogenic for T lymphocytes (5-8).
Generation and Culture of Human T Cell Clones. All T cell clones used in this study were derived from a single individual's mononuclear cells stimulated in mixed lymphocyte cultures (MLC) with the allogeneic EBV-transformed lymphoblastoid cell line, Laz 156. Cloning and recloning were performed as described (9) . Several alloreactive human T cell clones (CTSE-tv, CT4I, and CT4n) were grown in continuous culture for >15 mo, maintaining initial phenotype and functions. Optimal growth of T cell clones was obtained in the presence of a feeder cell suspension (irradiated autologous peripheral blood mononuclear cells plus irradiated Laz 156 cells) in IL-2-conditioned media, although proliferation also occurred in the presence of either irradiated Laz 156 or IL-2-conditioned medium.
Cytotoxic T Cell Clone CT8m. The cytotoxic T cell clone CT8III used in the present study was generated and propagated in culture as described above (9) . The phenotype of CT8m as determined with a panel of monoclonal antibodies by means of indirect immunofluorescence was TI-,T3+,T4-,T6-,TS+,TI 1+,T12+,Ia +. The target specificity as analyzed on a panel of HLA-typed target cells was HLA-A3. Moreover, the cytotoxic effector function of CT8m could be blocked by anti-HLA but not by anti-Ia antibodies on the target cell level.
Production and Characterization of Monoclonal Antibodies.
Monoclonal antibodies anti-T3A, anti-T4A, anti-T6, anti-TSA_c, and anti-T12 were produced as previously described (5, 10, 18) and used in ascites form. Monoclonal antibodies directed at human Ia-like antigens and flzmicroglobulin have been described (19) . To produce clonotypic antibodies, BALB/cJ mice were initially immunized intraperitoneally with 5 × 106 CT8m cells in phosphate-buffered saline. 10 d later, a booster injection with 5 × 106 CT8m cells i.p. was performed. 3 d before somatic fusion of immune splenocytes with NS-1 myeloma cells, two mice were injected intravenously and intraperitoneally with a total of 5 × 106 CTSni cells. After the animals were killed, immune splenocytes were obtained and fusion was performed as previously described (5, 10, 18) . Hybridoma growth was evident by 2 wk, and supernatants of hybridoma clones were subsequently screened for reactivity on CT8m by means of indirect immunofluorescence. Hybridomas that failed to produce antibodies reactive with CT8In were discarded. Reactive supernatants were then screened on a large panel of cell types. These included autologous and allogeneic resting peripheral blood cells (T cells, B cells, macrophages, granulocytes, and platelets); thymocytes; autologous and allogeneic activated T cells (mixed leukocyte reaction lymphohlasts, concanavalin A [Con A] lymphoblasts, T cell lines [2-4 mo old]); autologous and allogeneic B cell lines (Laz 509, Laz 156, and Laz 471); T cell tumor lines (CEM, Molt 4, and HSB); and tumor lines of non-T cell lineage (K562, HL-60, Laz 221, and KG1). Hybridomas producing antibody of interest were then cloned by limiting dilution, and individual hybrids were injected into pristine-rimed BALB/cJ mice. The resulting ascitic fluid was used as a source of antibody.
Phenotypic Analysis of T Cell Surface Antigens. Phenotype analysis of T lymphocytes was
performed by means of indirect immunotluorescence with a panel of monoclonal antibodies and goat anti-mouse F(ab')2 fluorescein isothioeyanate [FITC] on an Epics V cell sorter (Coulter Electronics Inc., Hialeah, FL) (9) . Quantitative histogram comparisons were performed with a Coulter Easy System lmmunoprogram on the basis of mean channel fluorescence.
Modulation of Surface Antigens by Monoclonal
Antibodies. CT8m cells at 1 × 106/ml were incubated with saturating amounts of one or another monoclonal antibody for 18 h at 37°C in final culture medium RPMI 1640 plus 12% human AB serum. Subsequently, the cells were washed three times and analyzed for expression of various cell surface antigens by means of indirect immunofluorescence on a fluorescence-activated cell sorter (FACS) before assessment of their functional properties (5, 1 i).
Competitive Antibody Binding Inhibition Studies. For these studies, directly FITC-labeled, purified monoclonal antibodies (anti-T3A, anti-TixA, and anti-TilB) were prepared. All experiments were performed at 4°C to prevent modulation of cell surface antigens. In the first incubation step, CTSm cells were incubated with saturating amounts of one or another unlabeled monoclonal antibody for 30 min. Then the cells were washed twice and incubated with directly FITC-labeled monoclonal antibody (30 min) before FACS analysis.
Investigation of Cell-Mediated Lympholysis.
To examine functional effects of monoclonal antibodies to T cell surface antigens on the cytotoxic effector function, clones were incubated for various periods (30 rain-18 h) with monoclonal antibodies at several dilutions or medium prior to addition of 51Cr-labeled targets. These experiments were performed at an effector/target (E/T) ratio of 20:1 in V-bottomed microtiter plates (Falcon Labware, Oxnard, CA) according to a standard method (20 clones was performed with Na I (New England Nuclear, Boston, MA) and catalyzed by lactoperoxidase. To 20 × l0 s cells suspended in 1 ml PBS were added successively 10 lal glucose (0.5 mol/liter), 5 pl NaI (5 × 104 tool/liter), 10/~1 lactoperoxidase (2 mg/ml), 1 mCi Na 131I, and 20 pl glucose oxidase (7.5 mU/ml). This mixture was incubated for 15 rain at room temperature followed by addition of 100/~1 NaI (1 mol/liter). After an additional 2 min of incubation, cells were washed four times in Hanks' balanced salt solution. The final pellet was lysed in 500 pl 1:5 diluted radioimmmune precipitation assay (RIPA) stock solution containing 1% Triton X-100 (RIPA stock solution: 0.1 mol/liter NaHuPO4, 1 mmol/liter phenylmethylsulfonyl fluoride, 10 mmol/liter EDTA, 10 mmol/liter EGTA, 10 mMol NaF, 1% deoxycholate sodium salt, 200 KIU/ml aprotinin, pH 7.2). The suspension was centrifuged for 5 rain at 1,120 g and the resulting supernatant was precleared twice using monoclonal antibody anti-T6 covalently linked to CnBr-activated Sepharose 4B (Pharmacia Fine Chemicals, Uppsala, Sweden), each for 60 min at 4°C, and subsequently centrifuged 5 min at 1,120 g. Precleared lysates were incubated with monoclonal antibodies bound to CnBr-activated Sepharose 4B for 2 h at 4°C. The resulting precipitate was subsequently washed five times in RIPA solution (stock 1:10 diluted) plus 1% Triton X-100 resuspended in gel buffer (0.125 tool/liter Tris-HCl, pH 6.8, containing 10% glycerol, 3% sodium dodecyl sulfate [SDS] , and 5% 2-mercaptoethanol) and boiled for 5 rain. SDS polyacrylamide gel electrophoresis (PAGE) was performed on a continuous vertical slab gel (12.5% polyacrylamide) for 14 h according to a modification of the Laemmli procedure (21).
Results
To produce monoclonal antibodies to clonally restricted antigen recognition structures on human T lymphocytes, BALB/cJ mice were immunized with the human cytotoxic T cell clone CT8m (phenotype: TI-,T3+,T4-,T6-,T8+,TII+,T12+,Ia+), which was previously shown to be specific for the HLA-A3 antigen. Subsequently, immune splenocytes were fused with the NS-1 mouse myeloma line by standard hybridization technique (3) . O f 221 individual hybridoma clones that were established in hypoxanthine, aminopterin, thymidine medium, 59 secreted monoclonal antibodies reactive with the immunizing clone CT8In. However, 43 of these 59 antibodies were also reactive with the autologous B lymphoblastoid cell line Laz 509 and were therefore most likely directed at either alloantigens or other broadly distributed cell surface molecules. In contrast, the remaining 16 antibodies were reactive with the immunizing clone but lacked reactivity with B cells, macrophages, granulocytes, platelets, B lymphoblastoid lines, myeloid lines, and other hematopoietic lines (see Materials and Methods).
Within the latter group, seven antibodies were reactive with the 76KD T8 surface structure (anti-T8D_a), one recognized the 20,000-tool wt T3 molecule (anti-T3B), and six were specific for activated but not resting T lymphocytes (anti-TAl_6). In addition, two antibodies, termed anti-TilA and anti-TiaB, reacted exclusively with the CTSIn clone and were of the IgG1 and IgM isotype, respectively.
Unlike the other 14 antibodies, anti-TilA and anti-TilB did not react with h u m a n thymocytes or resting or activated h u m a n peripheral T cells (both autologous or allogeneic). More importantly, these were also nonreactive with 80 additional individual alloreactive T cell clones derived from the same donor as CT8In. The pattern of antibody binding to the alloreactive TilA+TilB+ clone CT8nI, and CTSIv, a representative TilA-Tim-clone, is shown in the antigen-specific cytotoxic T cell clone CTSm, it was important to determine whether the surface structures that they defined were involved in antigen recognition.
To this end, anti-TitA and anti-Tim were incubated with CT8IN cells for various periods before assay of the clone's cytolytic and proliferative capacities. In parallel, the effects of several other T cell-specific monoelonal antibodies (anti-T3A, -T3B, -T8A, -T8c, and -T12) were investigated. As shown in Fig. 2 , at an E/T ratio of 20:1, CTSm cells were highly efficient (>50% specific lysis) in lysing the HLA A3 + B lymphoblastoid line Laz 156. Anti-T3A,B and anti-T8A both markedly inhibit CTL effector function of this clone (_<10% lysis), whereas anti-T8c and anti-T12 do not. These results are in keeping with earlier studies which indicated that both anti-T3 and anti-T8 monoclonal antibodies can inhibit T8 ÷ CTL (5, 8, 11) . In addition, they are consistent with the finding that not all anti-T8 antibodies mediate this effect (9, 10). More importantly, both anti-TilA and anti-Tim markedly inhibit the CT8m clone's cytotoxic effector capacity (<20 and <5% specific lysis, respectively). Although it is not shown, the fact that inhibitory effects of the monoclonal antibodies were observed at dilutions of ascites varying from 1:250 to 1:2,500 and were evident after <30 rain of preincubation with CTSm should be noted. However, the magnitude of the inhibitory effect increased with the length of preincubation.
Although by indirect immunofluorescence anti-Tiaa and anti-Tim reactivity appeared to be restricted to the CTSm clone, we also determined whether the functional effects of these antibodies on cytolytic activity were restricted to CT8In. As shown in Table I , anti-TilA and anti-Tim exclusively inhibited killing of t-he CT8m clone among a panel of five CTL clones tested. In contrast, the effects of anti-T3, anti-T4, and anti-T8 antibodies were not restricted to the CT8m clone. Anti-T3 monoclonal antibodies blocked all five CTL clones irregardless of their T4 + or T8 + subset derivation or specificity; anti-T4A inhibited cytolysis by the T4 + clones CT4I and CT4II and had no effect on killing by the T8 + clones CT8I, CT8II, and CT8m; and in a reciprocal fashion, anti-T8A and anti-T8B monoclonal antibodies inhibited killing of all three T8 ÷ CTL but not the two T4 CTL clones, CT4I and CT4II. Previous studies indicated that some human CTL clones not only specifically kill target cells but also proliferate to them in an antigen-specific fashion (5). To examine the effect of the anti-clonotypic antibodies on the antigen-specific proliferative capacity of clone CT8m, an additional series of experiments was performed. As shown in Table II , untreated CWSiii cells proliferate to both IL-2-containing supernatants as well as the allogeneic cell line Laz 156, to which they had been originally stimulated. Under these experimental conditions, antigen (Laz 156) is the stronger stimulus for CTSIII cell proliferation as judged by the greater [3H]TdR incorporation into CT8III with the former (>12,000 cpm vs. 2,714 cpm). In addition, the induction of clonal proliferation by the combination of alloantigen and IL-2 is greater than with either alone (17,152 cpm). Pretreatment of CTSIII with anti-Tiln or anti-Tim markedly reduces antigen-specific proliferation of the CT8III clone. Thus, whereas the untreated CT8m clone proliferated with >t2,000 counts of in proliferation of >80%. A similar reduction of proliferation was obtained with anti-T3B. That these effects were not simply due to an inactivation of the CT8Iu clone as a result of antibody treatment is clear from the fact that (a) anti-T 12 and anti-T8A have no inhibitory effects in this system (Table II) ; and (b) the anti-TilA, anti-Timor anti-T3B-treated CT8m clone has an augmented proliferative capacity to IL-2-containing supernatant (>10,000 cpm vs. <3,000 cpm). It should be emphasized that anti-TSA, in contrast to its ability to profoundly block cytolytic effector function by T8 + CTL clones, lacks any inhibitory effect on antigen-specific proliferation.
The observation that anti-T3, anti-TilA, and anti-Tim all inhibited antigen-specific proliferation and CTL effector function and enhanced IL-2 responsiveness of CT8m suggested that there might be a relationship between the cell surface structures defined by these antibodies. In this regard, previous studies (5) indicated that binding of anti-T3 antibodies to T cells at 37°C resulted in selective modulation and external shedding of the T3 molecular complex without affecting cell viability or altering expression of other known T cell surface structures including T1, T l l , T12, or T8 surface molecules. To determine whether anti-T3 induced modulation produced changes in surface expression of detectable Til)~ or Tila molecules, CT8In cells were first incubated with anti-T3B for 18 h at 37°C and washed to remove free monoclonal antibody; subsequently, cell reactivity was analyzed by indirect immunofluorescence on an Epics V cell sorter with a panel of monoclonal antibodies.
As shown in Fig. 3 , before modulation, all CT8m cells were reactive with anti-T3A, anti-TixA, anti-Tim, and anti-T8A (panels A-D, dark curves). In contrast, after modulation with anti-T3a, T3 antigen was no longer detectable (panel A, light curve). More importantly, anti-T3B-induced modulation also resulted in loss of the anti-Ti~A and anti-Tim surface epitopes (panels B and C, respectively). That this was not a nonspecific effect is evident from the observation that the T8 antigen density (panel To further investigate the relationship of the epitope defined by anti-T3 and those defined by anti-TilA and anti-Tim, both competitive antibody binding inhibition studies and immunoprecipitations were performed. As shown in Table III , unlabeled anti-T3A and anti-T3~ inhibited subsequent binding of directly FITC-labeled anti° T3A, whereas anti-TilA and anti-Tim did not. In a reciprocal fashion, unlabeled anti-T3A or anti-T3B failed to inhibit subsequent binding of directly FITC-labeled antiTiaA or anti-Tim. In contrast, either unlabeled anti-Til antibody was inhibitory for FITC-labeled anti-TilA or anti-Tim. Under no circumstances did unlabeled anti-T8A block binding of directly FITC-labeled anti-T3A, anti-TilA, or anti-Tim. Taken together, these findings would suggest that the surface epitopes recognized by antiTixA and anti-Tim are spacially related (or identical) to one another but clearly distinct from those defined by anti-T3 or anti-T8 antibodies.
To define biochemically the surface molecules detected by anti-TilA and anti-Tim, crsiii cells were labeled by lactoperoxidase technique with 13~I and immunoprecipitates from solubilized membranes subjected to SDS-PAGE. As a control, CTaIv, an additional autologous T8 ÷ CTL clone nonreactive with anti-TilA and anti-Tim, was tested in parallel. Fig. 4 shows that under reducing conditions, anti-Tim precipitated two distinct bands of ~49,000 and 43,000 mol wt, respectively, from the CT8III clone (channel C), but not the irrelevant cr8iv clone (channel D). In a parallel fashion, anti-Tim precipitated identical structures from the same CT8HI clone (panel E), but not the irrelevant CT8iv clone (channel F). Negative control precipitates from crsiii and CT8Iv using monoclonal antibody T6 are shown in channels A and B, respectively. Both the inability of the anti-clonotypic antibodies to inhibit anti-T3 cell surface binding and the present biochemical data are consistent with the notion that these two sets of antibodies are directed at different glycoproteins than the major 20,000-mol wt glycoprotein defined by anti-T3 antibodies. 
Discussion
In the present study, murine monoclonal antibodies were produced against a human T3+T8 + C T L clone, CTSm, with the view of defining components of its surface receptor structures for antigen. By first screening for reactivity on autologous B lymphoblastoid cells and other alloreactive clones using indirect immunofluorescence, antibodies to broadly distributed lymphoid lineage markers or allospecifieities were eliminated. Only 2 of 221 B-B hybridomas resulting from a single fusion between CT8m-immune BALB/cJ splenocytes and NS-1 myeloma cells secreted antibodies that were restricted in their reactivity to CTSIII; these were termed anti-TilA and antiTiIB. Anti-TiaA and anti-Tim did not react with thymocytes, resting or activated T lymphocytes, B lymphocytes, macrophages, granulocytes, platelets, or any of 80 additional clones from the same individual donor as the CTSm clone. In contrast, anti-T3, anti-T4, and anti-T8 reacted with all mature T lymphocytes, inducer T lymphocytes, and suppressor T lymphocytes, respectively (1, 2) . Moreover, all alloreactive human T cell clones were T3 + and expressed either the T4 or T8 surface molecules. Thus, unlike the previously defined antibodies, anti-TiaA and anti-Til~ recognized clonotypic structures.
Anti-TiaA and anti-Tim had striking effects on CTSm cell function: both inhibited its antigen-specific proliferative responses and CTL effector function. Because similar effects were observed with anti-T3 antibodies (5-8, 11) , we investigated the relationship of TilA, Tim, and T3 molecules in greater detail. It was found that all three surface structures were associated on CT8m because they co-modulated after binding either anti-TilA, anti-Tim, or anti-T3 antibodies. However, multiple lines of evidence indicated that these antibodies reacted with different surface epitopes: (a) the cellular distribution of anti-T3 reactivity was distinct from anti-TiaA and anti-Tim, as noted above; (b) anti-T3 antibody blocked the killing function of all CTL clones tested, whereas the effect of anti-TilA and anti-Tim was restricted to CT8m; (c) in competitive binding studies with FITC-labeled and unlabeled antibodies, neither anti-TilA nor anti-Tim inhibited anti-T3 binding to CT8m cells and vice versa, whereas anti-TilA and/or anti-TilB inhibited each other's binding to CT8III; and (d) unlike anti-T3A or anti-T3B, which precipitated a major 20,000-mol wt glycoprotein from all mature T cells and thymocytes (5, 22) , anti-TilA and anti-Tim were found to immunoprecipitate two bands at 49,000 and 43,000 tool wt under reducing conditions from the ~3aI-radiolabeled CT8m clone alone. The specificity of anti-Ti~A and anti-Tim for epitopes unique to the CT8m clone was further supported by the absence of detectable material on SDS-PAGE analysis of immunoprecipitates from three other T8 + CTL clones and a heterogeneous T cell population (predominantly T8 +) derived from the same donor as CT8m (Fig. 4 and data not shown) .
More recent studies (5, 11) have indicated that preincubation of clones with anti-T3 antibodies abrogated antigen-specific proliferation and CTL effector function of every population tested. After anti-T3 antibody surface binding at 37°C, the 20,000-mol wt T3 molecules were externally shed in a modulation process that required 18-24 h. Loss of antigen-specific function was evident when surface T3 was bound by anti-T3 before modulation and persisted in the post-modulation period when neither surface antibody nor T3 molecules were detectable on the clone. More importantly, after anti-T3-induced modulation, CTL recovered effective cytolytic activity in parallel with reexpression of surface T3 molecules (5) . That this effect was not simply due to the modulation process itself was evident from parallel studies in which a different antigen, T1, a 67,000-mol wt glycoprotein, was induced to modulate from T cell clones with anti-T1 antibody. In that case, no inhibition of T cell function was noted (5). Thus, both the appearance of T3 in late intrathymic ontogeny at the time of acquisition of immunologic competence and its critical role in T lymphocyte function (1, 4) suggested that it was closely linked to an important recognition receptor. Hence, the association of the 20,000-mol wt T3 molecule with clonotypic structures such as TilA and Tim involved in antigen recognition was not entirely unexpected.
It is likely that anti-TilA and anti-Tim define variable regions of the human T cell antigen receptor on CT8m because they recognize clonotypic structures and inhibit antigen-specific function. In contrast, the wide distribution within the T lineage of the 20,000-tool wt T3 glycoprotein defined by the presently existing anti-T3 antibodies suggests that, unlike anti-TiaA and anti-TiaB, they define a constant region of the antigen receptor complex. This does not exclude the possibility, however, that variability could exist within another portion of this structure or that it might possess antigen binding properties. In this regard, it is known that at least one other 25-28,000-mol wt structure is associated with the T3 molecular complex (22) . Biochemical analysis at the protein and DNA level will resolve this issue.
Two major subsets of T lymphocytes have been defined on the basis of their differential expression of either the T4 or T8 surface molecules. These are glycoproteins of molecular weight 62,000 and 76,000, respectively, which are unrelated to T3 (2) . Although cytotoxic effector T lymphocytes are derived from both of these populations, the target antigens they recognized are the products of different major histocompatibility complex (MHC) gene regions (9, 12) . Specifically, allosensitized T4 + T cells kill class II MHC antigens, whereas T8 + T cells kill class I MHC antigens.
The association between surface phenotype of a CTL and the class of MHC molecule that it recognized implied that the same subset restricted structures might be required in the facilitation of selective lysis of target antigens. This hypothesis has now been substantiated by the finding that monoclonal antibodies to the T4 or T8 glycoproteins selectively inhibit cytolytic effector function of T4 or T8 clones, respectively. Because their inhibitory effects can be bypassed by agglutination of CTL and target cells with the lectin Con A, these structures are probably not involved in the lytic mechanism itself (11, 23) . Similarly, it should be noted that Con A could reconstitute the capacity of the CT8m clone to kill the HLA-A3 alloantigen bearing target Laz 156, even in the presence of anti-T3, anti-TilA, or anti-Tim. However, in this case, killing specificity was lost because the CT8m clone killed HLA-A3 negative targets as well.
The effects of anti-T4 and anti-T8 antibodies are clearly distinct from those of anti-T3, or in the case of the CT8m clone, anti-Ti~A or anti-Tim, in one major respect. The former two antibodies, unlike the latter three, do not block antigen-specific proliferative responses by T cell clones. This suggests that the T4 and T8 glycoproteins may serve as subset-restricted association structures for nonpolymorphic determinants on classes of MHC gene products that may be required for efficient E/T interaction in CML rather than as components of the T cell antigen recognition receptor linked to T3, TilA, and Tim.
The observation that anti-T3, anti-Ti~, or anti-Tim pretreatment of CT8nI cells enhanced subsequent IL-2 responsiveness is important for several reasons. First, it provides strong evidence that the effects of these monoclonal antibodies on antigenspecific function were not due to trivial consequence of global diminution in clonal activity. Second, it suggests that in this one respect, the monoclonal antibodies triggered the clone in a similar fashion to specific alloantigen because both yield enhanced IL-2 responsiveness. Whether the basis of this effect is due to induction of endogenous IL-2 secretion by the CT8m clone itself, or alternatively, enhanced sensitivity to IL-2, for example, by means of alterations in the number or state of IL-2 receptors, is currently under investigation. In this regard, it is known that both major human T cell subsets produce IL-2 upon appropriate stimulation (24) . Furthermore, the above findings may in part account for the mitogenic effect of antiidiotypic heteroantisera on murine T cell clones, as previously reported (25) .
Previous attempts to characterize T cell receptor molecules have been largely biased by the assumption that they share certain similarities with surface immunoglobulin on B lymphocytes (see ref. 26 for review). In fact, analysis ofT cell idiotypic structures has used antisera generated to variable regions of secreted immunoglobulin. Although the existence of such idiotypes on T cells has been suggested by a multiplicity of functional studies whereby antiidiotypes produced effects on immunoregulatory T cell populations (27) (28) (29) , the precise nature of the T cell molecules defined by these antisera is still poorly understood. Furthermore, the lack of easily demonstrable Ig gene rearrangements in homogeneous murine T helper and T suppressor lines with JH and CH gene probes (30, 31) suggests that antigen recognition by T cells in all likelihood does not occur through structures closely analogous to those used by B lymphocytes.
The molecular weights of TitA and Tim in the human system appear to be strikingly similar to those of antigen-specific suppressor factors generated in a J(enopus laevis oocyte translation system using messenger RNA from a keyhole limpet hemocyaninspecific murine T-T hybridoma clone that consisted of two individual antigen binding molecules of molecular weights 29-30,000 and 45-62,000 (32, 33) . However, others (28, (34) (35) (36) (37) (38) (39) (40) (41) (42) (43) (44) (45) (46) (47) (48) reported suppressor factors and antigen-binding material that appear to be of different molecular weight and characteristics. Whether the reported differences result from the use of functionally distinct T cell populations, alterations resulting from the fusion process in the case of T-T hybridomas and/or differences between secreted and surface forms of the T cell receptor, is not known at the present time, but clearly, all possibilities remain open. The generation of monoclonal antibodies to cloned T cell populations may represent an advantageous approach to define T cell surface recognition structures because it makes no assumptions about the similarities between B and T cell receptor molecules. In addition, it allows for the development of probes to the cell surface receptor glycoproteins themselves as opposed to secreted antigen-specific products that may be significantly different from the intact membrane molecule. The use of cloned homogeneous T cells should furthermore provide the functional machinery to identify important biologic effects of anti-clonotypic antibodies on the immune response and yield the cellular material for precise biochemical and genetic studies.
Summary
Monoclonal antibodies were produced against a human cytotoxic T cell clone, CT81IX (specificity: HLA-A3), with the view of defining clonally restricted (clonotypic) surface molecules involved in its antigen recognition function. Two individual antibodies, termed anti-TilA and anti-TilB, reacted exclusively with the CT8m clone when tested on a panel of 80 additional clones from the same donor, resting or activated T cells, B cells, macrophages, thymocytes, or other hematopoietic cells. More importantly, the two antibodies inhibited cell-mediated killing and antigen-specific proliferation of the CTSIn clone but did not affect the functions of any other clone tested. This inhibition was not secondary to generalized abrogation of the CTSIII clone's function, because interleukin 2 responsiveness was enhanced. To examine the relationship of the structures defined by anti-clonotypic antibodies with known T cell surface molecules, antibody-induced modulation studies and competitive binding assays were performed. The results indicated that the clonotypic structures were associated with, but distinct from, the 20,000-tool wt T3 molecule expressed on all mature T lymphocytes. Moreover, in contrast to anti-T3, anti-TilA and anti-TilB each immunoprecipitated two molecules of 49,000 and 43,000-mol wt from l~lI-labeled CT8~I cells under reducing conditions. The development of monoclonal antibodies to such polymorphic T cell surface structures should provide important probes to further define the surface receptor for antigen.
Note added in proof." Since submission of this manuscript, we have produced an anticlonotypic monoclonal antibody, anti-Ti2A, to a surface structure on the T3+,T4+,T8-class II-specific CTL clone CT4II. The Ti~ clonotype, like TiIA and Tim on CTSm, is membrane associated with T3. As expected, anti-Ti~ selectively blocks antigen-specific proliferation and CTL effector function of CT4n and enhances its IL-2 responsiveness.
